RESPIRATORY DISEASE PSI is a leading, full-service CRO specializing in on-time delivery of clinical studies. PSI positions itself as a ‘no-nonsense’ CRO capable of saving our sponsors millions of development dollars by consistently meeting clinical trial timelines. PSI’s global reach supports the operations of clinical trials across multiple countries and continents. PSI’s dedicated Feasibility Department, comprised of medical specialists, laboratory experts, imaging specialists, logisticians and regulatory experts, has conducted feasibility across a wide range of respiratory diseases. When we apply this process to your trial and combine it with our knowledge of the nuances and complexities associated with respiratory trials, we are able to provide recommendations for the best choice of sites, geography and realistic timelines for your study. 250+ of our staff members hold Medical Degrees and many possess board-certifications in specialties such as pulmonology, internal medicine, hematology and oncology, pediatrics and neonatology. We have all the means to ensure that a team of experts will run your study.
PSI has the following Phase I-IV experience in diseases affecting the Respiratory Tract: Allergic Rhinitis
Lung Cancer
Asthma (adult and pediatric)
Respiratory Syncytial Virus (RSV)
Chronic Bronchitis
Ventilator Acquired Pneumonia
Community Acquired Pneumonia Chronic Obstructive Pulmonary Disease Cystic Fibrosis Hospital Acquired Pneumonia
I have found that PSI is the perfect choice for us a collaborating partner. Director of Clinical Research, Sweden
For more information about PSI, please visit our website WWW.PSI-CRO.COM or reach us at CONTACT@PSI-CRO.COM